Compare VUZI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VUZI | ORGO |
|---|---|---|
| Founded | 1997 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 303.5M | 348.6M |
| IPO Year | 2009 | 2016 |
| Metric | VUZI | ORGO |
|---|---|---|
| Price | $4.18 | $2.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | ★ 2.8M | 1.1M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.11 | ★ 1600.00 |
| EPS | ★ N/A | N/A |
| Revenue | $6,280,611.00 | ★ $564,169,000.00 |
| Revenue This Year | $103.32 | N/A |
| Revenue Next Year | N/A | $26.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 9.14 | ★ 17.04 |
| 52 Week Low | $1.83 | $2.04 |
| 52 Week High | $5.62 | $7.08 |
| Indicator | VUZI | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 56.82 | 42.23 |
| Support Level | $2.22 | $2.26 |
| Resistance Level | $5.62 | $2.67 |
| Average True Range (ATR) | 0.57 | 0.15 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 55.45 | 23.97 |
Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices and third-party original design manufacturer (ODM) and original equipment manufacturer (OEM) devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.